Leidos Holdings Croissance future
Future contrôle des critères 2/6
Leidos Holdings devrait augmenter ses bénéfices et son chiffre d'affaires de 5.8% et de 5.3% par an respectivement. Le BPA devrait croître de de 8.3% par an. Le rendement des capitaux propres devrait être 25.7% dans 3 ans.
Informations clés
5.8%
Taux de croissance des bénéfices
8.34%
Taux de croissance du BPA
| Professional Services croissance des bénéfices | 15.4% |
| Taux de croissance des recettes | 5.3% |
| Rendement futur des capitaux propres | 25.68% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 20 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
Seeking Alpha • May 09
Look Past Leidos Holdings' Shrinking Share Price To Its High Return On Equity
Summary Leidos Holdings is rated Buy, with a 10.4% upside target based on strong fundamentals and a widening gap between earnings and share price. LDOS's high return on equity (30.49%) and management's NorthStar 2030 strategy underpin expectations for continued growth and compounding returns. Recent price declines are attributed to macro factors like the U.S. government shutdown, not deterioration in LDOS's earnings or operational performance. Integration of ENTRUST and ongoing reliance on government contracts present risks, but improving fundamentals and guidance support a positive outlook. Read the full article on Seeking Alpha
Mise à jour du récit • May 02
LDOS: Defense Tech Contracts And AI Alliance Will Offset 2026 VBA Drag
The updated analyst price target for Leidos Holdings has been trimmed by about $5 to roughly $199 per share. Analysts factored in recent target cuts around mixed Q4 results, modestly lower revenue growth assumptions, a slightly higher discount rate, and a somewhat lower future P/E multiple, even as profit margin expectations edge up.Mise à jour du récit • Apr 17
LDOS: Defense Tech And AI Partnership Will Offset 2026 VBA Headwinds
Leidos Holdings' updated analyst price target has moved lower by about $5 per share to reflect a slightly higher discount rate, a reduced future P/E assumption, and tempered margin expectations, as analysts factor in mixed Q4 results, recent target cuts from several firms, and ongoing headwinds in Veterans Benefits Administration work, even as growth initiatives continue. Analyst Commentary Recent research updates on Leidos point to a more cautious valuation framework, even as some analysts still see upside tied to growth investments and capital allocation changes.Mise à jour du récit • Apr 03
LDOS: Defense Tech And AI Contracts Will Offset 2026 VBA Slowdown
Analysts have trimmed the average price target for Leidos Holdings to $209 from about $212, reflecting slightly higher discount rate assumptions, modestly adjusted growth and margin expectations, and mixed reactions to recent Q4 results and contract headwinds. Analyst Commentary Recent research paints a mixed picture around Leidos Holdings, with both optimistic and cautious views emerging after the latest Q4 report, updated guidance, and evolving contract exposure.Mise à jour du récit • Mar 19
LDOS: Defense Tech And AI Expansion Will Offset 2026 VBA Contract Slowdown
Analysts have trimmed the blended price target on Leidos Holdings by about $1.50 to roughly $212.50, reflecting slightly softer long term growth and margin assumptions after mixed Q4 results and evolving views on the VBA headwind and defense tech opportunities. Analyst Commentary Street research on Leidos Holdings has shifted toward a more balanced view, with price targets generally nudged lower and ratings clustered around Buy, Outperform, Hold, and Neutral.Mise à jour du récit • Mar 05
LDOS: Defense Tech And AI Shift Will Offset 2026 VBA Headwinds
Analysts have reduced their blended price target for Leidos Holdings by about $4 to roughly $214, reflecting recent Q4 updates, mixed views on growth in 2026, and ongoing debate around the impact of slower Veterans Benefits Administration work versus opportunities in defense tech and other growth segments. Analyst Commentary Street research on Leidos presents a split view, with several firms trimming price targets after Q4 while still highlighting long term growth opportunities in defense technology and other higher growth areas.Mise à jour du récit • Feb 18
LDOS: Defense Tech And AI Shift Will Support Premium Multiple
The updated fair value estimate for Leidos Holdings edges down to about $218 per share from roughly $219, as analysts adjust price targets lower, citing mixed Q4 results, a slowdown in Veterans Benefits Administration activity, and tempered views on future valuation and guidance, even as the company increases its focus on higher growth markets. Analyst Commentary Recent Street research on Leidos points to a split view, with some analysts focusing on long term growth opportunities and others stressing execution risks and valuation constraints following the latest Q4 report and guidance.
Nouveau récit • Feb 15
The Grid Modernizer: Leidos and the $2.4 Billion Bet on Sovereign AI and Energy
Leidos is entering its February 17, 2026, earnings call in a unique "valuation gap." While the stock is trading near $176 , our DCF analysis suggests an intrinsic floor of $227 , representing a 29% upside. The current market hesitation stems from "leverage shock" following the $2.4 billion acquisition of ENTRUST Solutions Group.Mise à jour du récit • Feb 04
LDOS: Entrust Acquisition And AI Partnerships Will Support Premium Multiple
Analysts nudged their blended price target on Leidos Holdings slightly higher to about US$219.31, reflecting a modestly higher assumed future P/E multiple while balancing recent target moves tied to enthusiasm around the Entrust acquisition and caution over potential 2026 contract headwinds. Analyst Commentary Recent research on Leidos highlights a split view, with some analysts leaning into the potential of the Entrust acquisition and others more focused on contract concentration and 2026 risk.Mise à jour du récit • Jan 21
LDOS: Health And Civil Strength And VA Contract Risk Will Shape Premium Multiple
Narrative Update: Leidos Holdings Analysts have trimmed their blended price target on Leidos Holdings by about $1 per share to $219, reflecting slightly more conservative assumptions on revenue growth, margins, and future P/E, after balancing recent target increases from firms citing strong execution and portfolio positioning with concerns around a key high margin contract and the timing of proving its sustainability. Analyst Commentary Recent research on Leidos highlights a mix of optimism around the core business and caution around a key contract that could affect medium term growth and valuation multiples.Mise à jour du récit • Jan 07
LDOS: Health And Civil Strength And Pipeline Visibility Will Support Premium Multiple
Analysts have nudged their fair value estimate for Leidos Holdings higher to about $219.85 from roughly $218.08, citing stronger recent earnings, solid Health & Civil margins, a 1.3x book to bill, a US$69b near term pipeline, and a view that the company merits a premium P/E multiple within government services. Analyst Commentary Bullish Takeaways Bullish analysts see the recent earnings beat as support for a higher fair value, pointing to execution in Health & Civil margins as a key driver of profitability.Mise à jour du récit • Dec 16
LDOS: Strong Health And Civil Margins Will Support Future Premium Multiple
Analysts have raised their price target on Leidos Holdings to approximately $218.08 per share from about $218.08. This reflects slightly stronger expectations for revenue growth and sustained margins, supported by robust book to bill trends, a sizable near term pipeline, and upside earnings performance with higher profitability guidance into 2025.Mise à jour du récit • Dec 02
LDOS: Strong Health And Civil Margins Will Support Continued Margin Upside
Leidos Holdings saw its average analyst price target rise from $210 to $230 as analysts highlighted robust Health & Civil margins, a strong contract pipeline, and increased profitability guidance following recent earnings results. Analyst Commentary Recent analyst reports have highlighted several factors influencing sentiment around Leidos Holdings following the latest earnings results and guidance updates.Mise à jour du récit • Nov 18
LDOS: Near-Term Contract Pipeline Will Drive Continued Margin Upside
Leidos Holdings' analyst price target has increased from $201.83 to $218.08 per share, as analysts cite strong margins in Health and Civil segments, a robust $69 billion pipeline, and raised profitability guidance as driving factors for the upward revision. Analyst Commentary Recent analyst reports have highlighted several factors that shape both the bullish and cautious outlooks for Leidos Holdings following its stronger-than-expected earnings performance and revised guidance.Article d’analyse • Nov 06
Leidos Holdings (NYSE:LDOS) Is Increasing Its Dividend To $0.43
Leidos Holdings, Inc. ( NYSE:LDOS ) will increase its dividend from last year's comparable payment on the 31st of...Mise à jour du récit • Nov 02
LDOS: Federal Health And Security Spending Will Drive Steady Performance Ahead
Leidos Holdings saw its analyst price target rise from approximately $198.50 to $201.83. Analysts cited the company’s ongoing momentum in health services, robust margins, and its positioning to benefit from expanding federal funding priorities.Mise à jour du récit • Oct 18
Government Funding And Digital Transformation Will Create Future Value
The average analyst price target for Leidos Holdings was raised by approximately $4 to $198.50. Analysts highlighted improving healthcare margins, stronger execution in health and defense services, and the company's positioning to benefit from recent government funding priorities.Mise à jour du récit • Oct 04
Government Funding And Digital Transformation Will Create Future Value
The analyst price target for Leidos Holdings has been increased by approximately $2 to $194.71, as analysts cite ongoing strength in healthcare margins, opportunities in defense solutions, and improved business execution as key factors supporting the higher valuation. Analyst Commentary Recent Street research updates reflect a generally positive outlook on Leidos Holdings, with multiple analysts raising their price targets and upgrading the stock in response to improved business execution and strong performance in key sectors.Mise à jour du récit • Sep 19
Government Funding And Digital Transformation Will Create Future Value
Upward analyst revisions for Leidos Holdings reflect confidence in its strategic investments in health and border security, strong healthcare margins, and effective leadership, resulting in a modest price target increase from $190.15 to $192.66. Analyst Commentary Bullish analysts highlight Leidos' strategic investments in veteran health, border security, and autonomous maritime, positioning the company to benefit from new government funding priorities.Article d’analyse • Sep 06
Here's Why Leidos Holdings (NYSE:LDOS) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Mise à jour du récit • Sep 04
Government Funding And Digital Transformation Will Create Future Value
Analysts maintain a positive outlook on Leidos Holdings due to strong execution in Health Services, favorable positioning for government funding priorities, increased management confidence, and a strategic pivot toward higher-margin growth sectors, resulting in an unchanged $186.69 price target. Analyst Commentary Continued strength and solid execution within Leidos' Health Services business, contributing to improved outlook and confidence.Article d’analyse • Jun 19
Does Leidos Holdings (NYSE:LDOS) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Seeking Alpha • Apr 15
Leidos: A Defense Company To Consider
Summary Leidos Holdings, Inc. operates in defense, IT security, data analytics, and healthcare, recently realigning into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Leidos has shown strong performance, boasting a 450% total return over the past decade, exceeding returns of the overall market. The company has been growing its dividend for a few years, but I think they could offer investors higher increases. Read the full article on Seeking AlphaSeeking Alpha • Feb 02
Leidos: Fears Are Overblown, Take Advantage Of Market Uncertainty
Summary Leidos' shares have dropped significantly due to policy uncertainties, presenting a buying opportunity given its strong backlog and free cash flow generation. The company's Q3 '24 results showed robust growth with a 44% EPS increase and a $40.6 billion backlog, signaling future revenue stability. Despite political risks, Leidos' valuation is attractive at 10.3x EV/EBITDA, with strong dividend and share buyback potential. I rate Leidos a 'strong buy' due to its discounted valuation, solid financial position, and growth prospects in Health & Civil and National Security segments. Read the full article on Seeking AlphaSeeking Alpha • Nov 22
Leidos: Not Enough Margin Of Safety Despite Creating Value In A Low Growth Sector
Summary LDOS has consistently created shareholder value through a mix of organic growth and acquisitions. Despite improving operating and capital efficiencies, LDOS's returns have not shown an improving trend, and its valuation currently does not provide enough margin of safety. LDOS is financially sound with a good reinvestment rate and cash flow. But I recommend waiting for a 15% price drop before buying. Read the full article on Seeking AlphaPrévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 20,050 | 1,646 | 1,794 | 2,033 | 8 |
| 12/31/2027 | 19,135 | 1,546 | 1,640 | 1,884 | 14 |
| 12/31/2026 | 18,233 | 1,428 | 1,479 | 1,803 | 14 |
| 4/3/2026 | 17,329 | 1,413 | 1,859 | 1,993 | N/A |
| 1/2/2026 | 17,174 | 1,448 | 1,625 | 1,750 | N/A |
| 10/3/2025 | 17,332 | 1,405 | 1,338 | 1,506 | N/A |
| 7/4/2025 | 17,053 | 1,402 | 1,282 | 1,442 | N/A |
| 4/4/2025 | 16,932 | 1,333 | 1,226 | 1,380 | N/A |
| 1/3/2025 | 16,662 | 1,254 | 1,286 | 1,435 | N/A |
| 9/27/2024 | 16,277 | 1,199 | 1,304 | 1,445 | N/A |
| 6/28/2024 | 16,008 | 436 | 1,425 | 1,593 | N/A |
| 3/29/2024 | 15,714 | 321 | 1,191 | 1,376 | N/A |
| 12/29/2023 | 15,438 | 199 | 980 | 1,187 | N/A |
| 9/29/2023 | 15,155 | 147 | 804 | 986 | N/A |
| 6/30/2023 | 14,842 | 708 | 761 | 920 | N/A |
| 3/31/2023 | 14,601 | 672 | 661 | 801 | N/A |
| 12/30/2022 | 14,396 | 685 | 863 | 992 | N/A |
| 9/30/2022 | 14,190 | 682 | 968 | 1,077 | N/A |
| 7/1/2022 | 14,065 | 725 | 807 | 913 | N/A |
| 4/1/2022 | 13,916 | 723 | 779 | 885 | N/A |
| 12/31/2021 | 13,737 | 753 | 929 | 1,033 | N/A |
| 10/1/2021 | 13,498 | 776 | 635 | 769 | N/A |
| 7/2/2021 | 13,257 | 734 | 656 | 796 | N/A |
| 4/2/2021 | 12,723 | 718 | 1,036 | 1,201 | N/A |
| 1/1/2021 | 12,297 | 628 | 1,151 | 1,334 | N/A |
| 10/2/2020 | 11,999 | 612 | 1,381 | 1,555 | N/A |
| 7/3/2020 | 11,592 | 610 | 1,147 | 1,312 | N/A |
| 4/3/2020 | 11,406 | 593 | 941 | 1,076 | N/A |
| 1/3/2020 | 11,094 | 667 | N/A | 992 | N/A |
| 9/27/2019 | 10,787 | 674 | N/A | 927 | N/A |
| 6/28/2019 | 10,527 | 660 | N/A | 949 | N/A |
| 3/29/2019 | 10,328 | 668 | N/A | 1,034 | N/A |
| 12/28/2018 | 10,194 | 581 | N/A | 768 | N/A |
| 9/28/2018 | 10,063 | 507 | N/A | 828 | N/A |
| 6/29/2018 | 9,991 | 442 | N/A | 724 | N/A |
| 3/30/2018 | 10,033 | 396 | N/A | 619 | N/A |
| 12/29/2017 | 10,170 | 366 | N/A | 526 | N/A |
| 9/29/2017 | 10,229 | 311 | N/A | 483 | N/A |
| 6/30/2017 | 9,594 | 320 | N/A | 486 | N/A |
| 3/31/2017 | 8,311 | 263 | N/A | 392 | N/A |
| 12/30/2016 | 7,043 | 244 | N/A | 449 | N/A |
| 9/30/2016 | 5,803 | 341 | N/A | 365 | N/A |
| 7/1/2016 | 5,237 | 299 | N/A | 364 | N/A |
| 4/1/2016 | 5,206 | 295 | N/A | 443 | N/A |
| 1/1/2016 | 5,140 | 265 | N/A | 409 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de LDOS ( 5.8% par an) est supérieure au taux d'épargne ( 3.5% ).
Bénéfices vs marché: Les bénéfices de LDOS ( 5.8% par an) devraient croître plus lentement que le marché US ( 16.8% par an).
Croissance élevée des bénéfices: Les bénéfices de LDOS devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de LDOS ( 5.3% par an) devrait croître plus lentement que le marché de US ( 11.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de LDOS ( 5.3% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de LDOS devrait être élevé dans 3 ans ( 25.7 %)
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/22 12:02 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/04/03 |
| Revenus annuels | 2026/01/02 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Leidos Holdings, Inc. est couverte par 24 analystes. 14 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| John Eade | Argus Research Company |
| Peter Arment | Baird |
| David Strauss | Barclays |